Boeing (BA) Stock Analysis 2026: $89.5B Revenue, Turnaround Under Ortberg, 737 MAX Ramp — Q1 Earnings April 22

Boeing (BA) Stock Analysis 2026: $89.5B Revenue, Turnaround Under Ortberg, 737 MAX Ramp — Q1 Earnings April 22

Boeing ($BA) is simultaneously one of the most important and most troubled industrial companies on Earth. The $175 billion aerospace giant has been navigating a multi-year crisis spanning a 737 MAX safety scandal, a COVID-era demand collapse, a 787 Dreamliner production quality halt, an IAM machinist strike, and persistent losses in its fixed-price defense contracts. Boeing reports Q1 2026 earnings on April 22, 2026 — tomorrow.

Under new CEO Kelly Ortberg (appointed August 2024), Boeing is attempting to stabilize operations, ramp 737 MAX deliveries, and return to cash generation. The market prices this story at 158x forward earnings — a valuation that reflects extreme optimism about eventual recovery, not current profitability.

Fundamental Snapshot

Valuation Analysis: Not a Value Play — A Recovery Bet

Our multi-method model assigns Boeing a Margin of Safety of -206.8% — one of the most deeply negative readings in our screener. This reflects reality: Boeing is generating operating losses, carries a near-zero book value (distorted by years of losses and heavy debt), and requires multiples expansion in its favor through the conservative methods we use.

Graham Number: At EPS $2.48 and book value $6.94/share, Graham Number = v(22.5 — $2.48 — $6.94) — $19.65 — far below the $223 market price. Boeing's book value is essentially a rounding error relative to its $270B+ in debt and lease obligations.

Operating losses: Operating margin of -3.18% means Boeing is losing money on every dollar of revenue from core operations. The 2.5% net profit margin is positive due to below-the-line items (favorable tax provisions, investment income). This is not sustainable as an ongoing condition.

Forward PE 158x: The market is betting that Boeing returns to meaningful GAAP profitability within 2-3 years. Forward EPS estimates are approximately $1.40/share — thin, and at risk if the turnaround stalls.

Analyst consensus: 34 analysts cover Boeing. The consensus target of $265.92 implies +19.2% upside from $223. This reflects analyst optimism about Ortberg's recovery plan and 737 MAX production ramp. The 52-week range ($156.47 ? $254.35) shows the stock recovered strongly from its lows.

The honest picture: Buying Boeing at $223 is a turnaround bet, not a fundamental value investment. The investment thesis depends entirely on execution: normalized 737 MAX production rates, defense margin recovery, and cash generation by 2027-2028. If execution slips, the stock will re-rate significantly lower.

The 737 MAX Crisis and Production Ramp

Boeing's 737 MAX program has been the defining challenge of the past seven years.

2019 groundings: Following two fatal crashes (Lion Air 2018, Ethiopian Airlines 2019) linked to the MCAS flight control system, the 737 MAX was grounded globally. Boeing spent 20 months and billions of dollars on recertification, deliveries resumed late 2020.

January 2024 door plug incident: An Alaska Airlines 737 MAX 9 experienced a door plug blowout mid-flight. The FAA launched a comprehensive review of Boeing's manufacturing quality systems, imposing a production rate cap at 38 aircraft per month. Boeing had been targeting 50/month.

Production cap impact: The production cap directly limits revenue and cash flow. Every month below 50 aircraft/month represents approximately $1B in deferred cash. Boeing's path to positive cash generation requires reaching and sustaining higher production rates.

Kelly Ortberg's mandate: Ortberg took over with a clear directive: stabilize production quality, pass FAA audits, and ramp delivery rates. Q1 2026 will reveal whether that ramp is materializing.

Defense Segment: Fixed-Price Contract Losses

Boeing's Defense, Space & Security segment has been a persistent source of losses, driven by a portfolio of poorly-priced fixed-price development contracts.

KC-46 Pegasus tanker: The Air Force aerial refueling tanker program has cost Boeing billions in overruns. Progress continues but margin recovery is slow.

T-7 Red Hawk trainer: Next-generation Air Force trainer aircraft with significant development cost overruns.

Space and Launch: The Starliner spacecraft program (NASA Commercial Crew) encountered propulsion failures that prevented a manned return mission in 2024, requiring NASA astronauts to return via SpaceX. This damaged Boeing's space credibility and may affect future NASA contracting.

The improvement thesis: Ortberg has flagged the defense segment as a priority reset. Fixed-price programs are moving toward completion, and Boeing is taking a more disciplined approach to new contract pricing. Improvement will take years, not quarters.

Q1 2026 Earnings Preview (April 22)

The most important data points to watch when Boeing reports tomorrow:

737 MAX deliveries: The number of MAX aircraft delivered in Q1 is the single most important indicator. Each delivery of ~$55M (list price) drives revenue and cash. Compare to the prior quarter trend.

Production rate update: Has Boeing secured FAA approval to increase production beyond 38/month? Any increase is a meaningful positive catalyst.

Cash flow guidance: Boeing suspended its dividend and has been burning significant cash. Updated free cash flow guidance for full-year 2026 is the market's key focus.

Defense charge risk: Watch for any additional charges on fixed-price defense contracts. A large charge (as has occurred multiple times in recent years) would be a negative catalyst.

Backlog confirmation: Boeing's commercial backlog is approximately 5,600+ aircraft — years of demand. The backlog is not in question. What matters is delivery rate.

Ortberg commentary: Listen carefully to the CEO's tone on production stability, quality systems, and FAA relationship. Confidence here is essential.

The Bull Case for Boeing Recovery

Despite all of the above challenges, the bull case for Boeing is genuinely credible:

Duopoly position: Boeing and Airbus together control 99%+ of large commercial jet orders. No other manufacturer can challenge this duopoly within the next decade. Every airline that needs jets eventually returns to Boeing or Airbus — there is no alternative.

Order backlog: ~5,600 commercial aircraft on order represents roughly 7-8 years of revenue at current delivery rates. Even at 50 deliveries per month, Boeing has runway well into the 2030s.

Defense recovery: As fixed-price programs conclude, the defense segment loss drag reduces. New contract wins (advanced fighter propulsion, space systems) carry better economics.

Balance sheet stabilized: The 2024 capital raise of $21B removed the near-term liquidity concern. Boeing can fund the turnaround.

Analyst consensus: 34 analysts with an average target of $265.92 suggests Wall Street broadly believes in the recovery trajectory.

Risk Factors

Production execution failure: If Boeing cannot ramp 737 MAX beyond 38/month due to quality issues or FAA restrictions, the recovery timeline extends significantly and cash burn continues.

New safety incident: Another Boeing aircraft safety event would be catastrophic for the brand and could trigger a new regulatory crackdown. This tail risk is impossible to quantify but must be acknowledged.

Defense charges: Another large charge on a fixed-price defense program would reduce confidence in the defense segment trajectory.

Balance sheet stress: Boeing carries approximately $50B+ in long-term debt. If cash generation remains negative into 2027, refinancing risk increases and a potential dilutive offering cannot be ruled out.

Airbus competition: Airbus has been taking market share during Boeing's difficulties. Airlines that switched to A320neo family aircraft may not easily return to Boeing.

What Our Valuation Tools Show

• P/E Ratio Calculator: At 90x trailing PE and ~158x forward PE, Boeing's valuation is driven by recovery expectations, not current earnings. The stock cannot be analyzed using traditional PE framing.
• EV/EBITDA Calculator: At 27.26x EV/EBITDA, Boeing is priced on a normalized EBITDA basis that assumes successful recovery.
• Graham Number Calculator: The $19.65 Graham Number reflects why traditional value metrics fail here — Boeing's book value does not capture the franchise value of its duopoly position and backlog.

Our screener gives Boeing a SAVE score of 34.3/100 — one of the lowest in the platform — and risk score 46.4/100. The low SAVE score reflects the combination of negative MoS, near-zero profit margin, operating losses, and extremely elevated multiples. The risk score captures both operational and financial risk, though it does not fully quantify the tail risk of another safety incident.

Bottom Line

Boeing is not an investment for value-focused investors. Our model's -206.8% MoS confirms that — conservative methods cannot justify the current price. Boeing is a turnaround bet on one of the most iconic industrial franchises in the world.

The core question is simple: Can Kelly Ortberg successfully ramp 737 MAX production, stabilize quality systems, and generate consistent cash flow by 2027? If yes, Boeing could trade significantly higher — analysts see $266 (+19%). If execution continues to slip, downside could be substantial from current levels.

Tomorrow's Q1 2026 earnings call will provide the most important data points yet on whether Ortberg's Boeing is on track.

Next earnings: April 22, 2026 (Q1 2026)

This analysis uses Equity Rank's multi-method valuation model combining Graham Number, EPV, DCF, and comparable multiples. SAVE score and MoS reflect model outputs, not investment recommendations. All data as of April 19, 2026. Not investment advice. See full disclaimer below.

Equity Rank is an independent financial research and analysis platform. We are not registered investment advisers. Nothing on this platform constitutes a recommendation to purchase, hold, or divest any security. All content is for informational and educational purposes only. Investors should conduct their own due diligence and consult a licensed financial professional before making investment decisions.